| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | MYH7 MYH8 HIP1 MYH13 SPTAN1 HNRNPU WASH6P SYNE2 TLN2 SETD3 UTRN MYH7B SYNE1 AVIL PHACTR3 VASH2 MYH15 CTNNA2 TNNI1 CROCC MYBPC2 | 1.62e-08 | 479 | 200 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH7 MYH8 HIP1 MYH13 SPTAN1 GAS8 HNRNPU WASH6P SYNE2 TLN2 CAMSAP1 SETD3 KIF17 UTRN MYH7B KNSTRN SYNE1 USH1C IFT88 CCT5 FEZ1 AVIL PHACTR3 MYLIP VASH2 CDK5RAP2 MYH15 CTNNA2 TRAK2 TNNI1 CROCC MYBPC2 | 5.06e-08 | 1099 | 200 | 32 | GO:0008092 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH7 MYH8 MYH13 SPTAN1 CFAP221 CAMSAP1 CNGA2 STRN3 PPP3CB PPP3CC CDK5RAP2 MYH15 | 3.73e-06 | 230 | 200 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | actin filament binding | MYH7 MYH8 HIP1 MYH13 SPTAN1 TLN2 MYH7B SYNE1 AVIL MYH15 CTNNA2 | 1.90e-05 | 227 | 200 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.68e-05 | 38 | 200 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 MYH8 ABCB7 EIF4A3 ABCC2 KIF17 HSPA9 HSP90AA4P RAD51B DNAH7 CCT5 SLFN11 MTREX SMC1B | 1.51e-04 | 441 | 200 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 MYH8 ABCB7 MYH13 EIF4A3 ABCC2 KIF17 HSPA9 HSP90AA4P RAD51B MYH7B DNAH7 CCT5 MYH15 SLFN11 MTREX SMC1B | 1.57e-04 | 614 | 200 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.88e-04 | 118 | 200 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.40e-04 | 130 | 200 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 9.79e-04 | 5 | 200 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 9.79e-04 | 5 | 200 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 9.95e-04 | 20 | 200 | 3 | GO:0042800 | |
| GeneOntologyCellularComponent | microtubule organizing center | HK2 CEP85L GAS8 HMMR TTC19 HNRNPU WASH6P WDR35 CAMSAP1 KIF17 LCA5 RANBP1 RPGRIP1L KNSTRN CCDC77 TEK ARL2 TBC1D31 RESF1 IFT88 CCT5 FEZ1 STEEP1 CCDC68 LRRCC1 CDK5RAP2 LZTS2 PATJ CROCC | 1.77e-08 | 919 | 201 | 29 | GO:0005815 |
| GeneOntologyCellularComponent | myosin filament | 1.12e-07 | 25 | 201 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | centrosome | HK2 CEP85L HMMR TTC19 HNRNPU WASH6P WDR35 LCA5 RANBP1 RPGRIP1L KNSTRN CCDC77 TEK ARL2 TBC1D31 IFT88 CCT5 FEZ1 STEEP1 LRRCC1 CDK5RAP2 LZTS2 PATJ CROCC | 4.21e-07 | 770 | 201 | 24 | GO:0005813 |
| GeneOntologyCellularComponent | supramolecular fiber | TPT1 MYH7 MYH8 MYH13 SPTAN1 GAS8 EVPL HNRNPU SYNE2 CAMSAP1 KIF17 RPGRIP1L DSP MYH7B KNSTRN SYNE1 TEK DNAH7 PPP3CB SHANK2 CCT5 FEZ1 AVIL CDK5RAP2 MYH15 AKAP13 LZTS2 TNNI1 CEP170B MYBPC2 | 1.03e-06 | 1179 | 201 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPT1 MYH7 MYH8 MYH13 SPTAN1 GAS8 EVPL HNRNPU SYNE2 CAMSAP1 KIF17 RPGRIP1L DSP MYH7B KNSTRN SYNE1 TEK DNAH7 PPP3CB SHANK2 CCT5 FEZ1 AVIL CDK5RAP2 MYH15 AKAP13 LZTS2 TNNI1 CEP170B MYBPC2 | 1.18e-06 | 1187 | 201 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | myosin II complex | 6.42e-06 | 28 | 201 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 2.16e-05 | 59 | 201 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | MYH7 MYH8 MYH13 SPTAN1 SYNE2 MYH7B SYNE1 PPP3CB MYH15 TNNI1 MYBPC2 | 7.10e-05 | 273 | 201 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH7 MYH8 MYH13 SPTAN1 SYNE2 MYH7B SYNE1 PPP3CB MYH15 TNNI1 MYBPC2 | 1.21e-04 | 290 | 201 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | cytoplasmic region | GAS8 HNRNPU CFAP221 WDR35 KIF17 LCA5 RANBP1 RPGRIP1L DNAH7 IFT88 CTNNA2 TRAK2 | 2.00e-04 | 360 | 201 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | fascia adherens | 2.33e-04 | 13 | 201 | 3 | GO:0005916 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | GAS8 HNRNPU CFAP221 WDR35 KIF17 LCA5 RANBP1 RPGRIP1L DNAH7 IFT88 TRAK2 | 2.62e-04 | 317 | 201 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | non-motile cilium membrane | 2.74e-04 | 3 | 201 | 2 | GO:0098804 | |
| GeneOntologyCellularComponent | cilium | GAS8 ADCY6 CFAP221 WDR35 KIF17 CNGA2 CNGA4 LCA5 RPGRIP1L USH1C DNAH7 ARL2 TBC1D31 SHANK2 PPP3CC IFT88 CCDC68 CROCC CFAP44 PMFBP1 | 4.32e-04 | 898 | 201 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | muscle myosin complex | 4.47e-04 | 16 | 201 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH7 MYH8 HIP1 MYH13 SPTAN1 TLN2 MYH16 MYH7B TEK AVIL MYH15 AKAP13 CTNNA2 TNNI1 CROCC | 4.78e-04 | 576 | 201 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | non-motile cilium | 6.37e-04 | 196 | 201 | 8 | GO:0097730 | |
| GeneOntologyCellularComponent | axoneme | 9.09e-04 | 207 | 201 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 9.37e-04 | 208 | 201 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPT1 GAS8 EVPL HNRNPU CAMSAP1 KIF17 RPGRIP1L DSP KNSTRN TEK DNAH7 SHANK2 CCT5 FEZ1 AVIL CDK5RAP2 AKAP13 LZTS2 CEP170B | 1.12e-03 | 899 | 201 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.16e-03 | 48 | 201 | 4 | GO:0032391 | |
| GeneOntologyCellularComponent | calcineurin complex | 1.35e-03 | 6 | 201 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 1.87e-03 | 7 | 201 | 2 | GO:0017071 | |
| GeneOntologyCellularComponent | microtubule | TPT1 GAS8 HNRNPU CAMSAP1 KIF17 RPGRIP1L KNSTRN DNAH7 CCT5 FEZ1 CDK5RAP2 LZTS2 CEP170B | 2.03e-03 | 533 | 201 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.29e-03 | 139 | 201 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | desmosome | 2.40e-03 | 28 | 201 | 3 | GO:0030057 | |
| Domain | Myosin_N | 3.42e-07 | 15 | 197 | 5 | PF02736 | |
| Domain | Myosin_N | 3.42e-07 | 15 | 197 | 5 | IPR004009 | |
| Domain | Spectrin_repeat | 4.95e-07 | 29 | 197 | 6 | IPR002017 | |
| Domain | SPEC | 9.20e-07 | 32 | 197 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.20e-07 | 32 | 197 | 6 | IPR018159 | |
| Domain | Myosin_tail_1 | 9.51e-07 | 18 | 197 | 5 | PF01576 | |
| Domain | Myosin_tail | 9.51e-07 | 18 | 197 | 5 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.28e-06 | 19 | 197 | 5 | IPR027401 | |
| Domain | - | 1.28e-06 | 19 | 197 | 5 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 4.69e-05 | 38 | 197 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.69e-05 | 38 | 197 | 5 | PS51456 | |
| Domain | Myosin_head | 4.69e-05 | 38 | 197 | 5 | PF00063 | |
| Domain | MYSc | 4.69e-05 | 38 | 197 | 5 | SM00242 | |
| Domain | Spectrin | 9.09e-05 | 23 | 197 | 4 | PF00435 | |
| Domain | TFIID_TAF13 | 1.11e-04 | 2 | 197 | 2 | IPR003195 | |
| Domain | TFIID-18kDa | 1.11e-04 | 2 | 197 | 2 | PF02269 | |
| Domain | - | 1.31e-04 | 10 | 197 | 3 | 1.10.220.60 | |
| Domain | Grip | 1.79e-04 | 11 | 197 | 3 | SM00755 | |
| Domain | GRIP | 1.79e-04 | 11 | 197 | 3 | PF01465 | |
| Domain | TPR-like_helical_dom | CLTCL1 TTC4 TTC19 NAA25 SEL1L3 WDR35 ZC3H7B RGPD2 ZC3H7A IFT88 | 1.90e-04 | 233 | 197 | 10 | IPR011990 |
| Domain | GRIP_dom | 2.37e-04 | 12 | 197 | 3 | IPR000237 | |
| Domain | GRIP | 2.37e-04 | 12 | 197 | 3 | PS50913 | |
| Domain | - | 3.61e-04 | 207 | 197 | 9 | 1.25.40.10 | |
| Domain | ILWEQ_dom | 6.55e-04 | 4 | 197 | 2 | IPR002558 | |
| Domain | KASH | 6.55e-04 | 4 | 197 | 2 | IPR012315 | |
| Domain | ILWEQ | 6.55e-04 | 4 | 197 | 2 | SM00307 | |
| Domain | KASH | 6.55e-04 | 4 | 197 | 2 | PS51049 | |
| Domain | CLZ | 6.55e-04 | 4 | 197 | 2 | PF16526 | |
| Domain | ILWEQ | 6.55e-04 | 4 | 197 | 2 | PD011820 | |
| Domain | KASH | 6.55e-04 | 4 | 197 | 2 | SM01249 | |
| Domain | - | 6.55e-04 | 4 | 197 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 6.55e-04 | 4 | 197 | 2 | PF01608 | |
| Domain | I_LWEQ | 6.55e-04 | 4 | 197 | 2 | PS50945 | |
| Domain | KASH | 6.55e-04 | 4 | 197 | 2 | PF10541 | |
| Domain | CLZ_dom | 6.55e-04 | 4 | 197 | 2 | IPR032406 | |
| Domain | Prefoldin | 9.80e-04 | 72 | 197 | 5 | IPR009053 | |
| Domain | TPR-contain_dom | 1.08e-03 | 150 | 197 | 7 | IPR013026 | |
| Pathway | KEGG_TIGHT_JUNCTION | 9.74e-06 | 132 | 147 | 9 | M11355 | |
| Pubmed | TPT1 MYH7 MYH8 CLTCL1 MYH13 STAG1 SPOCK1 EIF4A3 SPTAN1 SANBR SRP14 ZNF318 ADCY6 HNRNPU SAFB SYNE2 ABCC2 NIPBL HSPA9 RAD51B RGPD2 RANBP1 STRN3 RPL36 DSP MYH7B SYNE1 U2SURP NUCB2 CCDC77 RNF17 ZC3H7A MLIP TBC1D31 SHANK2 IFT88 AVIL PES1 VASH2 MYH15 SPEN MYBPC2 | 6.78e-18 | 1442 | 205 | 42 | 35575683 | |
| Pubmed | PRPF31 HIP1 KMT2B ORC3 NACA SRPK1 GPATCH4 ZNF318 HMMR GUF1 UTP20 ZC3H7B UTRN NIPBL TARBP2 STRN3 SUPT3H RPL36 CAD SYNE1 UFL1 ZC3H7A SHANK2 PPP3CC CCT5 SLC4A1AP PES1 CTNNA2 LZTS2 MTREX PATJ CROCC SPEN CEP170B | 1.47e-11 | 1497 | 205 | 34 | 31527615 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPT1 CLTCL1 GATAD2A MYH13 RPS2 EIF4A3 SPTAN1 NACA SRP14 SRPK1 HNRNPU MIEF1 TLN2 UTRN NIPBL HSPA9 HSP90AA4P RANBP1 RPL36 DSP U2SURP CCT5 SLC4A1AP MRPS33 SMARCD3 | 4.54e-11 | 847 | 205 | 25 | 35235311 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 HK2 GATAD2A RPS2 EIF4A3 SPTAN1 NACA SRP14 SRPK1 GPATCH4 MCM10 HNRNPU GUF1 SAFB MCM3AP UTP20 UTRN NIPBL HSPA9 GOLGA4 RANBP1 RPL36 CAD DSP U2SURP FASTKD2 ZC3H7A CCT5 PES1 AKAP13 MTREX | 1.05e-10 | 1353 | 205 | 31 | 29467282 |
| Pubmed | CCDC134 PRPF31 TPT1 TRAF3 ABCB7 RPS2 EIF4A3 SPTAN1 SRPK1 SCRN1 GPATCH4 ERGIC2 HNRNPU XPO5 SYNE2 NIPBL HSPA9 RANBP1 CAD DSP U2SURP NUCB2 UFL1 FASTKD2 ARL2 CCT5 PES1 AKAP13 CTNNA2 CROCC | 1.74e-10 | 1297 | 205 | 30 | 33545068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PRPF31 TRAF1 HK2 RPS2 EIF4A3 SPTAN1 NACA SRP14 GPATCH4 F2 HNRNPU SAFB XPO5 UTP20 TLN2 NIPBL HSPA9 GOLGA4 RANBP1 RPL36 CAD DSP SYNE1 U2SURP UFL1 FASTKD2 PRDM7 CCT5 PES1 MTREX SPEN | 3.73e-10 | 1425 | 205 | 31 | 30948266 |
| Pubmed | RPS2 SPTAN1 SRPK1 ZNF318 XPO5 MCM3AP SYNE2 UTP20 UTRN NIPBL HSPA9 CAD DSP U2SURP ARF3 CCT5 PES1 MTREX SPEN SYMPK | 2.38e-09 | 653 | 205 | 20 | 22586326 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RPS2 EIF4A3 NACA GPATCH4 ZNF318 HNRNPU SAFB HSPA9 CAD DSP CCT5 STEEP1 SMARCD3 CLSPN SYMPK | 4.08e-09 | 357 | 205 | 15 | 37059091 |
| Pubmed | ABCB7 STXBP4 SPTAN1 SRP14 SRPK1 HMMR CACTIN GUF1 SYNE2 EIF2AK3 TARBP2 HSPA9 GOLGA4 DMXL2 RPL36 CAD SYNE1 NUCB2 UFL1 FASTKD2 CCDC77 ZC3H7A ARL2 TBC1D31 SLC4A1AP PES1 MRPS33 CDK5RAP2 AKAP13 LZTS2 | 4.22e-09 | 1487 | 205 | 30 | 33957083 | |
| Pubmed | PRPF31 MYH7 EIF4A3 SRPK1 HNRNPU MYH16 CAD DSP U2SURP SLC4A1AP LZTS2 SYMPK | 8.63e-09 | 220 | 205 | 12 | 24550385 | |
| Pubmed | PRPF31 TPT1 KMT2B GATAD2A ORC3 EIF4A3 SRP14 ZNF318 HMMR HNRNPU SAFB XPO5 NIPBL HSPA9 RANBP1 CAD KNSTRN U2SURP RESF1 CCT5 PES1 STEEP1 SLFN11 MTREX SPEN | 9.89e-09 | 1103 | 205 | 25 | 34189442 | |
| Pubmed | STXBP4 SPTAN1 CACTIN ZFYVE9 SYNE2 STX17 UTRN GOLGA4 RPL36 CAD RPGRIP1L DSP CCDC77 ARL2 TBC1D31 PPP3CB PPP3CC CCT5 SLC4A1AP PES1 CDK5RAP2 SLFN11 LZTS2 SYMPK | 1.67e-08 | 1049 | 205 | 24 | 27880917 | |
| Pubmed | PRPF31 RPS2 SPTAN1 HNRNPU SYNE2 HSPA9 SYNE1 CCT5 CTNNA2 CROCC CFAP44 | 1.68e-08 | 187 | 205 | 11 | 26460568 | |
| Pubmed | CLTCL1 KMT2B GATAD2A SRP14 ZNF318 MCM10 CACTIN SUPT3H PPP3CB PES1 STEEP1 MTREX CLSPN SPEN | 1.69e-08 | 339 | 205 | 14 | 30415952 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPF31 GATAD2A RPS2 ORC3 EIF4A3 NACA SRP14 SRPK1 GPATCH4 ERGIC2 HNRNPU CACTIN GUF1 SAFB XPO5 NIPBL HSPA9 RANBP1 CAD U2SURP UFL1 FASTKD2 ARF3 ARL2 CCT5 PES1 MTREX | 1.99e-08 | 1318 | 205 | 27 | 30463901 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PRPF31 TRPC4AP STAG1 ORC3 EIF4A3 STXBP4 NACA GPATCH4 HMMR ERGIC2 HNRNPU NDUFAF7 TLN2 NIPBL RGPD2 RANBP1 STRN3 KNSTRN SYNE1 U2SURP ARF3 THBS1 ARL2 CDK5RAP2 CEP170B | 2.43e-08 | 1155 | 205 | 25 | 20360068 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PRPF31 GATAD2A RPS2 EIF4A3 NACA ZNF318 HNRNPU SAFB SYNE2 UTP20 UTRN NIPBL HSPA9 RPL36 CAD DSP SYNE1 U2SURP UFL1 CCT5 PES1 MTREX SPEN | 4.75e-08 | 1024 | 205 | 23 | 24711643 |
| Pubmed | PRPF31 RPS2 EIF4A3 NACA SRP14 SRPK1 GPATCH4 HNRNPU SAFB TLN2 HSPA9 RANBP1 RPL36 DSP U2SURP PES1 MRPS33 MTREX SPEN | 8.14e-08 | 731 | 205 | 19 | 29298432 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STXBP4 ZNF318 TTC4 MCM3AP CAD RPGRIP1L DSP ZC3H7A RESF1 SLFN11 LZTS2 MTREX CLSPN PATJ CFAP44 SPEN CEP170B | 9.05e-08 | 588 | 205 | 17 | 38580884 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCB7 GPBP1 CEP85L STXBP4 BRPF1 CAMSAP1 HSPA9 LCA5 STRN3 RPGRIP1L DSP KNSTRN CCDC77 DNAH7 ARF3 ZC3H7A TBC1D31 CCT5 LRRCC1 CEP170B | 1.91e-07 | 853 | 205 | 20 | 28718761 |
| Pubmed | Evolution of sarcomeric myosin heavy chain genes: evidence from fish. | 2.02e-07 | 3 | 205 | 3 | 15014174 | |
| Pubmed | MYH13 RPS2 GPATCH4 ZNF318 MCM10 CDC42EP2 MIEF1 GCC1 CAMSAP1 HSPA9 GOLGA4 RPGRIP1L DNAH7 ARF3 ARL2 CCT5 CDK5RAP2 CLSPN SPEN | 2.08e-07 | 777 | 205 | 19 | 35844135 | |
| Pubmed | TRAF3 SPTAN1 ZNF318 HNRNPU SYNE2 TLN2 CAMSAP1 NIPBL HSPA9 GOLGA4 RGPD2 STRN3 DMXL2 CAD SYNE1 ARF3 PPP3CB SHANK2 CDK5RAP2 CTNNA2 CEP170B | 3.06e-07 | 963 | 205 | 21 | 28671696 | |
| Pubmed | HK2 ORC3 RPS6KA1 NACA SRPK1 HMMR ERGIC2 ADCY6 HNRNPU WASH6P ZC3H7B SLC25A17 DMXL2 AKAP13 MTREX CLSPN PATJ | 3.70e-07 | 650 | 205 | 17 | 38777146 | |
| Pubmed | TPT1 STAG1 RPS2 EIF4A3 SPTAN1 NACA SRP14 EVPL HNRNPU SAFB NIPBL HSPA9 RPL36 DSP PES1 MTREX SMC1B | 3.86e-07 | 652 | 205 | 17 | 31180492 | |
| Pubmed | PRPF31 RPS2 EIF4A3 SPTAN1 NACA SRP14 HNRNPU SAFB HSPA9 CAD DSP U2SURP CCT5 PES1 | 4.24e-07 | 441 | 205 | 14 | 31239290 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PRPF31 GATAD2A RPS2 EIF4A3 SPTAN1 NACA SRPK1 EVPL HMMR HNRNPU SAFB UTP20 HSPA9 RPL36 CAD DSP THBS1 PPP3CB CCT5 PES1 LZTS2 MTREX PATJ SPEN | 4.64e-07 | 1257 | 205 | 24 | 36526897 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PRPF31 RPS2 ORC3 EIF4A3 SRP14 MCM10 HNRNPU SAFB XPO5 UTP20 HSPA9 RPL36 DSP U2SURP ARF3 CCT5 SLC4A1AP PES1 MTREX CLSPN SYMPK | 4.72e-07 | 989 | 205 | 21 | 36424410 |
| Pubmed | GATAD2A MYH13 SPTAN1 NACA SRP14 SRPK1 GPATCH4 HMMR F2 CACTIN MCM3AP MIEF1 TARBP2 HSPA9 TCEA3 DSP KNSTRN CCDC77 ARL2 CCT5 PES1 MRPS33 CTNNA2 LZTS2 MTREX | 6.11e-07 | 1371 | 205 | 25 | 36244648 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPS2 EIF4A3 SPTAN1 NACA SRP14 SRPK1 GPATCH4 HNRNPU CACTIN HSPA9 RPL36 CAD DSP U2SURP CCT5 PES1 MTREX | 6.61e-07 | 678 | 205 | 17 | 30209976 |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 11919279 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 19948655 | ||
| Pubmed | TPT1 MYH7 HK2 RPS2 SPTAN1 NACA SRP14 HNRNPU UTRN HSPA9 RPL36 U2SURP ARL2 CCT5 STEEP1 | 8.35e-07 | 538 | 205 | 15 | 28524877 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRPF31 GPBP1 CEP85L STXBP4 SPTAN1 SYNE2 MIEF1 CAMSAP1 UTRN GOLGA4 BICC1 DSP DNAH7 RESF1 DCP1B AKAP13 MTREX PATJ CEP170B | 9.69e-07 | 861 | 205 | 19 | 36931259 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPS2 EIF4A3 SPTAN1 NACA SRP14 GPATCH4 HNRNPU CACTIN SAFB UTP20 HSPA9 HSP90AA4P RPL36 CAD DSP SYNE1 U2SURP CCT5 PES1 STEEP1 | 1.01e-06 | 949 | 205 | 20 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPF31 HK2 GATAD2A RPS2 EIF4A3 SPTAN1 NACA SRP14 SRPK1 GPATCH4 HNRNPU SYNE2 NIPBL HSPA9 GOLGA4 RPL36 CAD DSP U2SURP UFL1 CCT5 SLC4A1AP MRPS33 AKAP13 MTREX | 1.08e-06 | 1415 | 205 | 25 | 28515276 |
| Pubmed | 1.44e-06 | 234 | 205 | 10 | 36243803 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PRPF31 CLTCL1 RPS2 EIF4A3 SPTAN1 HNRNPU HSPA9 STRN3 CAD DSP PPP3CB CCT5 CTNNA2 LZTS2 CLSPN SYMPK | 1.45e-06 | 639 | 205 | 16 | 23443559 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | SPTAN1 NACA GAS8 XPO5 WDR35 HSPA9 GOLGA4 RANBP1 STRN3 CAD RPGRIP1L DSP THBS1 IFT88 MYBPC2 | 1.50e-06 | 564 | 205 | 15 | 21565611 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | ZNF318 MCM3AP CAMSAP1 RPGRIP1L DSP U2SURP LZTS2 SPEN CEP170B | 1.62e-06 | 184 | 205 | 9 | 32908313 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | PRPF31 RPS2 EIF4A3 SRP14 SRPK1 HNRNPU CACTIN SAFB XPO5 UTP20 ZC3H7B HSPA9 SYNE1 U2SURP FASTKD2 ZC3H7A PES1 SPEN | 1.63e-06 | 807 | 205 | 18 | 22681889 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TPT1 CLTCL1 SPOCK1 RPS2 EIF4A3 SPTAN1 HNRNPU GUF1 SAFB BRPF1 UTRN RPL36 CAD DSP SYNE1 ARF3 CCT5 AKAP13 | 1.63e-06 | 807 | 205 | 18 | 30575818 |
| Pubmed | PRPF31 NACA MCM10 TTC4 MIEF1 CAMSAP1 GOLGA4 RPGRIP1L NUCB2 ZC3H7A TBC1D31 DCP1B PES1 AKAP13 CLSPN PATJ CROCC | 1.91e-06 | 733 | 205 | 17 | 34672954 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | STAG1 ORC3 EIF4A3 SPTAN1 HNRNPU XPO5 MED12L TLN2 NIPBL DSP U2SURP RNF17 CCT5 MTREX SYMPK | 2.20e-06 | 582 | 205 | 15 | 20467437 |
| Pubmed | SRPK1 HMMR SYNE2 CAMSAP1 RPGRIP1L ZC3H7A TBC1D31 CDK5RAP2 LZTS2 CEP170B | 2.71e-06 | 251 | 205 | 10 | 29778605 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRPF31 KMT2B GATAD2A RPS2 ORC3 EIF4A3 SRP14 GPATCH4 ZNF318 HNRNPU CACTIN SAFB UTP20 NIPBL HSPA9 SUPT3H RPL36 DSP U2SURP STEEP1 MTREX SPEN SYMPK | 2.73e-06 | 1294 | 205 | 23 | 30804502 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ABCB7 HK2 RPS2 GPATCH4 TTC4 TTC19 GUF1 NDUFAF7 SYNE2 MIEF1 EIF2AK3 HSPA9 STRN3 RPL36 CAD RPGRIP1L SYNE1 UFL1 FASTKD2 CCDC77 CCT5 MRPS33 CDK5RAP2 TRAK2 MTFR2 | 2.91e-06 | 1496 | 205 | 25 | 32877691 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | PRPF31 RPS2 SPTAN1 GPATCH4 HNRNPU HSPA9 U2SURP CCT5 SLC4A1AP PES1 MTREX | 3.15e-06 | 316 | 205 | 11 | 31665637 |
| Pubmed | PRPF31 KMT2B GATAD2A RPS2 SRP14 SRPK1 EVPL GPATCH4 HNRNPU SAFB BRPF1 UTP20 KAZN RPL36 U2SURP PES1 MTREX SYMPK | 3.20e-06 | 847 | 205 | 18 | 35850772 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | PRPF31 GATAD2A RPS2 EIF4A3 SRPK1 GPATCH4 HNRNPU SAFB HSPA9 RPL36 DSP U2SURP PES1 MTREX SPEN | 3.52e-06 | 605 | 205 | 15 | 28977666 |
| Pubmed | CCDC134 TRAF1 HK2 KMT2B STXBP4 ADCY6 TTC19 GCC1 KAZN ZC3H7B KIF17 USH1C ARF3 LZTS2 SPEN | 3.73e-06 | 608 | 205 | 15 | 16713569 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PRPF31 ZMYND11 KMT2B GATAD2A STAG1 GPATCH4 MCM10 BMI1 CACTIN BRPF1 NIPBL SLC4A1AP PES1 STEEP1 SPEN | 3.73e-06 | 608 | 205 | 15 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B SPTAN1 ZNF318 ADCY6 CACTIN SAFB BRPF1 UTP20 TLN2 NIPBL GOLGA4 STRN3 DSP UFL1 SLC4A1AP SPEN SYMPK | 3.93e-06 | 774 | 205 | 17 | 15302935 |
| Pubmed | PRPF31 RPS2 EIF4A3 SPTAN1 MCM10 HNRNPU SAFB TAF13 HSPA9 CCT5 SLFN11 MTREX | 3.98e-06 | 390 | 205 | 12 | 17643375 | |
| Pubmed | 3.98e-06 | 6 | 205 | 3 | 20138174 | ||
| Pubmed | HK2 RPS2 SPTAN1 NACA SANBR SCRN1 HNRNPU SAFB TLN2 CAMSAP1 HSPA9 RGPD2 STRN3 DMXL2 CAD DSP U2SURP SHANK2 CCT5 CTNNA2 CEP170B | 4.36e-06 | 1139 | 205 | 21 | 36417873 | |
| Pubmed | GATAD2A RPS2 ORC3 EIF4A3 SRP14 SRPK1 MCM10 TTC4 HNRNPU TARBP2 HSPA9 HSP90AA4P RANBP1 RPL36 CAD FASTKD2 RESF1 IFT88 CCT5 WDR87 STEEP1 MRPS33 MTREX | 4.56e-06 | 1335 | 205 | 23 | 29229926 | |
| Pubmed | PRPF31 EIF4A3 SRP14 GPATCH4 HNRNPU ZC3H7B TARBP2 HSPA9 BICC1 DSP U2SURP PES1 MTREX | 4.88e-06 | 469 | 205 | 13 | 37314180 | |
| Pubmed | PRPF31 GATAD2A STAG1 NACA HMMR TTC4 SAFB TLN2 CAMSAP1 GOLGA4 STRN3 SLC4A1AP STEEP1 | 5.23e-06 | 472 | 205 | 13 | 38943005 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 SPTAN1 F2 BHMT WASH6P SAFB TLN2 RPL36 DSP UFL1 PREX2 THBS1 CCT5 | 5.59e-06 | 475 | 205 | 13 | 31040226 |
| Pubmed | PRPF31 RPS2 EIF4A3 SPTAN1 NACA HNRNPU SAFB HSPA9 CAD DSP U2SURP CCT5 SLC4A1AP MTREX | 5.68e-06 | 551 | 205 | 14 | 34728620 | |
| Pubmed | PRPF31 RPS2 EIF4A3 SPTAN1 SRP14 SRPK1 GPATCH4 HNRNPU SAFB RPL36 U2SURP FASTKD2 PES1 MRPS33 MTREX SYMPK | 5.84e-06 | 713 | 205 | 16 | 29802200 | |
| Pubmed | RAPGEF5 ADCY6 MAP3K4 XPO5 MCM3AP SEL1L3 KIF17 SYNE1 TRAK2 CROCC SPEN CEP170B | 6.13e-06 | 407 | 205 | 12 | 12693553 | |
| Pubmed | TPT1 RPS2 ORC3 EIF4A3 NACA SRP14 SCRN1 HNRNPU HSPA9 GOLGA4 RANBP1 RPL36 CAD DSP SYNE1 CCT5 PES1 | 6.37e-06 | 803 | 205 | 17 | 36517590 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | PRPF31 MYH13 RPS2 SPTAN1 SRP14 HNRNPU HSPA9 RPL36 CAD DSP U2SURP CCT5 SLC4A1AP CFAP44 | 6.55e-06 | 558 | 205 | 14 | 27591049 |
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 35210422 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PRPF31 SPOCK1 RPS2 EIF4A3 SPTAN1 SRP14 HNRNPU SAFB NIPBL DMXL2 RPL36 CAD DSP SYNE1 U2SURP UFL1 PES1 SMARCD3 SPEN SYMPK | 7.18e-06 | 1082 | 205 | 20 | 38697112 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH7 MYH8 ABCB7 CLTCL1 MYH13 SPTAN1 SRP14 HSPA9 RGPD2 RANBP1 RPL36 CAD DSP MYH7B CCT5 | 7.84e-06 | 647 | 205 | 15 | 26618866 |
| Pubmed | 8.33e-06 | 225 | 205 | 9 | 12168954 | ||
| Pubmed | MYH7 MYH8 HK2 TTC19 SYNE2 MED12L UTRN HSPA9 DMXL2 DSP SYNE1 CDK5RAP2 MYBPC2 | 9.07e-06 | 497 | 205 | 13 | 23414517 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | GPBP1 EIF4A3 STXBP4 SPTAN1 ZNF318 MCM10 WDR35 CAMSAP1 CAD KNSTRN ZC3H7A DCP1B CCT5 MYLIP CDK5RAP2 LZTS2 PATJ SYMPK | 1.02e-05 | 922 | 205 | 18 | 27609421 |
| Pubmed | PRPF31 KMT2B GATAD2A RPS2 SPTAN1 ZNF318 WASH6P CACTIN UTRN U2SURP CCT5 SLC4A1AP STEEP1 | 1.10e-05 | 506 | 205 | 13 | 30890647 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | EIF4A3 SRP14 SRPK1 GPATCH4 TARBP2 U2SURP UFL1 FASTKD2 DCP1B MTFR2 MTREX | 1.19e-05 | 364 | 205 | 11 | 24778252 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPS2 STXBP4 NACA GPATCH4 ZNF318 HNRNPU SAFB CAMSAP1 UTRN NIPBL HSPA9 RANBP1 STRN3 DSP U2SURP PES1 STEEP1 SLFN11 | 1.21e-05 | 934 | 205 | 18 | 33916271 |
| Pubmed | PRPF31 ABCB7 RPS2 SPTAN1 SRPK1 EIF2AK3 HSPA9 CAD RPGRIP1L U2SURP THBS1 CCT5 TRAK2 | 1.27e-05 | 513 | 205 | 13 | 25798074 | |
| Pubmed | 1.69e-05 | 54 | 205 | 5 | 25496667 | ||
| Pubmed | ABCB7 STXBP4 NACA TTC4 CACTIN NAA25 MCM3AP ARL2 TBC1D31 SNAPC1 MTREX CLSPN | 1.70e-05 | 451 | 205 | 12 | 30033366 | |
| Pubmed | RPS2 EIF4A3 NACA SRP14 SRPK1 GPATCH4 HNRNPU SAFB RPL36 CAD U2SURP PES1 MTREX PATJ | 1.94e-05 | 615 | 205 | 14 | 31048545 | |
| Pubmed | 1.99e-05 | 251 | 205 | 9 | 27507650 | ||
| Pubmed | SPTAN1 NACA HNRNPU SAFB HSPA9 RANBP1 CAD DSP SYNE1 CCT5 PES1 SLFN11 | 2.20e-05 | 463 | 205 | 12 | 34901782 | |
| Pubmed | 2.47e-05 | 97 | 205 | 6 | 22360420 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.47e-05 | 258 | 205 | 9 | 37794589 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | PRPF31 RPS2 EIF4A3 SPTAN1 NACA SRPK1 HNRNPU SAFB HSPA9 RPL36 CAD SYNE1 U2SURP CCT5 MTREX | 2.47e-05 | 714 | 205 | 15 | 28302793 |
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 2.59e-05 | 145 | 205 | 7 | 27049334 | |
| Pubmed | 2.62e-05 | 59 | 205 | 5 | 32382008 | ||
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 2.66e-05 | 200 | 205 | 8 | 35546148 | |
| Pubmed | 2.71e-05 | 146 | 205 | 7 | 21399614 | ||
| Pubmed | PRPF31 TPT1 RPS2 EIF4A3 SRP14 HNRNPU BMI1 ZC3H7B TARBP2 GOLGA4 FASTKD2 MREG ZC3H7A STEEP1 TRAK2 | 2.86e-05 | 723 | 205 | 15 | 34133714 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.07e-05 | 332 | 205 | 10 | 32786267 | |
| Pubmed | 3.28e-05 | 102 | 205 | 6 | 10231032 | ||
| Pubmed | 3.29e-05 | 206 | 205 | 8 | 22174317 | ||
| Pubmed | Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma. | 3.46e-05 | 2 | 205 | 2 | 20717685 | |
| Pubmed | Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. | 3.46e-05 | 2 | 205 | 2 | 17452456 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 3.46e-05 | 2 | 205 | 2 | 24931616 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 15817447 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11509566 | ||
| Pubmed | BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer. | 3.46e-05 | 2 | 205 | 2 | 20170541 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 2435757 | ||
| Pubmed | Myosin gene mutation correlates with anatomical changes in the human lineage. | 3.46e-05 | 2 | 205 | 2 | 15042088 | |
| Interaction | H3C1 interactions | ZMYND11 KMT2B GATAD2A GPBP1 STAG1 SPTAN1 NACA SRP14 SRPK1 GPATCH4 HNRNPU BMI1 CACTIN BRPF1 CAMSAP1 NIPBL RAD51B RPL36 DSP SYNE1 U2SURP THBS1 WDR87 PES1 STEEP1 MYH15 SLFN11 SPEN | 6.79e-08 | 901 | 198 | 28 | int:H3C1 |
| Interaction | CIT interactions | PRPF31 HIP1 CLTCL1 STAG1 RPS2 ORC3 EIF4A3 STXBP4 SPTAN1 NACA SRP14 SRPK1 GPATCH4 MAP3K4 HNRNPU CACTIN SAFB XPO5 SYNE2 UTP20 NIPBL GOLGA4 HSP90AA4P RANBP1 RPL36 CAD HTR1B DSP SYNE1 ARF3 CCT5 PES1 CDK5RAP2 MTREX PATJ SYMPK | 2.17e-07 | 1450 | 198 | 36 | int:CIT |
| Interaction | SLX4 interactions | RPS2 EIF4A3 NACA GPATCH4 ZNF318 MCM10 HNRNPU ZNF518A SAFB NIPBL HSPA9 CAD DSP CCDC77 RESF1 CCT5 PES1 STEEP1 SMARCD3 CLSPN SYMPK | 2.34e-07 | 572 | 198 | 21 | int:SLX4 |
| Interaction | TRIM37 interactions | MYH7 TRAF1 TRAF3 MYH13 SPTAN1 NACA ZNF318 MCM10 HNRNPU BMI1 MCM3AP CAMSAP1 HSPA9 RPL36 RPGRIP1L DSP KNSTRN U2SURP CDK5RAP2 LZTS2 SPEN CEP170B | 2.80e-07 | 630 | 198 | 22 | int:TRIM37 |
| Interaction | EED interactions | TPT1 HIP1 PCGF2 HK2 GATAD2A STAG1 RPS2 EIF4A3 RPS6KA1 SPTAN1 SRP14 HNRNPU BMI1 NAA25 SAFB XPO5 UTP20 KIF17 RAB3IL1 NIPBL HSPA9 RPL36 DSP ARF3 ARL2 TBC1D31 CCT5 PES1 LZTS2 MTREX CROCC SPEN CEP170B SYMPK | 1.68e-06 | 1445 | 198 | 34 | int:EED |
| Interaction | PCNT interactions | CEP85L SPTAN1 WDR35 UTRN NIPBL RANBP1 DMXL2 RPGRIP1L KNSTRN SYNE1 FEZ1 CDK5RAP2 | 4.95e-06 | 241 | 198 | 12 | int:PCNT |
| Interaction | CENPA interactions | PRPF31 KMT2B GATAD2A ORC3 GPATCH4 MCM10 HNRNPU BMI1 CACTIN BRPF1 UTP20 NIPBL PES1 STEEP1 SLFN11 | 5.13e-06 | 377 | 198 | 15 | int:CENPA |
| Interaction | AGBL4 interactions | 5.64e-06 | 70 | 198 | 7 | int:AGBL4 | |
| Interaction | LATS1 interactions | PRPF31 MYH7 TRAF1 MYH8 MYH13 STXBP4 SPTAN1 HSP90AA4P CAD U2SURP CCDC77 DCP1B CDK5RAP2 LZTS2 PATJ MYBPC2 | 7.71e-06 | 440 | 198 | 16 | int:LATS1 |
| Interaction | CDC5L interactions | ORC3 EIF4A3 SPTAN1 SRP14 SRPK1 MCM10 HNRNPU CACTIN XPO5 MED12L TLN2 NIPBL DSP SYNE1 U2SURP UFL1 RNF17 CCT5 STEEP1 SLFN11 MTREX SPEN SYMPK | 1.21e-05 | 855 | 198 | 23 | int:CDC5L |
| Interaction | PPWD1 interactions | 1.60e-05 | 113 | 198 | 8 | int:PPWD1 | |
| Interaction | ACTC1 interactions | PRPF31 KMT2B GATAD2A RPS2 EIF4A3 SPTAN1 ZNF318 WASH6P CACTIN SYNE2 UTRN SYNE1 U2SURP UFL1 CCT5 SLC4A1AP PHACTR3 STEEP1 CDK5RAP2 SMARCD3 | 1.76e-05 | 694 | 198 | 20 | int:ACTC1 |
| Interaction | KIAA0753 interactions | HNRNPU BRPF1 GCC1 CAMSAP1 LCA5 RPGRIP1L CCDC77 TBC1D31 LZTS2 | 2.57e-05 | 157 | 198 | 9 | int:KIAA0753 |
| Interaction | PCM1 interactions | CEP85L GAS8 HMMR MCM10 CAMSAP1 LCA5 RPGRIP1L DSP KNSTRN CCDC77 TBC1D31 LRRCC1 CDK5RAP2 FAM9B CEP170B | 2.70e-05 | 434 | 198 | 15 | int:PCM1 |
| Interaction | LCA5 interactions | 3.32e-05 | 125 | 198 | 8 | int:LCA5 | |
| Interaction | DHX8 interactions | SRPK1 GPATCH4 ZNF318 CACTIN SAFB RPL36 U2SURP STEEP1 SLFN11 MTREX SPEN SYMPK | 3.37e-05 | 292 | 198 | 12 | int:DHX8 |
| Interaction | TERF2IP interactions | KMT2B GATAD2A ORC3 SRP14 GPATCH4 ZNF318 MCM10 HNRNPU CACTIN NIPBL SUPT3H U2SURP SLC4A1AP STEEP1 CLSPN SPEN SYMPK | 3.39e-05 | 552 | 198 | 17 | int:TERF2IP |
| Interaction | GAN interactions | PRPF31 RPS2 SPTAN1 HNRNPU SYNE2 HSPA9 SYNE1 CCT5 CTNNA2 CROCC CFAP44 | 4.32e-05 | 253 | 198 | 11 | int:GAN |
| Interaction | SIRT7 interactions | RPS2 SPTAN1 SRPK1 ZNF318 XPO5 MCM3AP SYNE2 UTP20 UTRN NIPBL HSPA9 CAD DSP U2SURP ARF3 CCT5 PES1 MTREX SPEN SYMPK | 4.69e-05 | 744 | 198 | 20 | int:SIRT7 |
| Interaction | NUP43 interactions | KMT2B GATAD2A GPATCH4 ZNF318 ZNF518A CACTIN SAFB MCM3AP SYNE2 UTP20 NIPBL RANBP1 DSP ARL2 RESF1 CCT5 SLFN11 SPEN | 4.75e-05 | 625 | 198 | 18 | int:NUP43 |
| Interaction | NINL interactions | GPBP1 STXBP4 NACA MCM10 GCC1 CAMSAP1 LCA5 RANBP1 RPGRIP1L DSP CCDC77 ARF3 DCP1B LZTS2 CEP170B | 4.99e-05 | 458 | 198 | 15 | int:NINL |
| Interaction | NIN interactions | MYH13 CEP85L HMMR CAMSAP1 LCA5 RPGRIP1L KNSTRN CCDC77 TBC1D31 CCT5 CCDC68 LRRCC1 CEP170B | 5.85e-05 | 359 | 198 | 13 | int:NIN |
| Interaction | NDC80 interactions | CEP85L HMMR XPO5 SYNE2 CAMSAP1 RPGRIP1L CCDC77 TBC1D31 CCDC68 LRRCC1 CDK5RAP2 CEP170B | 6.38e-05 | 312 | 198 | 12 | int:NDC80 |
| Interaction | STK3 interactions | 7.80e-05 | 181 | 198 | 9 | int:STK3 | |
| Interaction | PRPF8 interactions | PRPF31 ZMYND11 RPS2 EIF4A3 NACA SRP14 SRPK1 HNRNPU BMI1 CACTIN HSPA9 GOLGA4 RPL36 DSP U2SURP UFL1 CCT5 SLC4A1AP MTREX SPEN | 8.37e-05 | 776 | 198 | 20 | int:PRPF8 |
| Interaction | PRC1 interactions | PRPF31 CLTCL1 RPS2 EIF4A3 SPTAN1 NACA SRP14 MAP3K4 HNRNPU SAFB XPO5 UTP20 HSP90AA4P RPL36 DSP SYNE1 MLIP CCT5 PES1 CCDC68 CDK5RAP2 PATJ SPEN | 8.96e-05 | 973 | 198 | 23 | int:PRC1 |
| Interaction | TRIM36 interactions | 9.07e-05 | 144 | 198 | 8 | int:TRIM36 | |
| Interaction | CEBPA interactions | PRPF31 TPT1 KMT2B GATAD2A STAG1 ORC3 EIF4A3 SPTAN1 SRP14 ZNF318 HMMR HNRNPU SAFB XPO5 NIPBL HSPA9 RANBP1 CAD KNSTRN U2SURP RESF1 CCT5 PES1 STEEP1 SLFN11 MTREX SPEN | 9.10e-05 | 1245 | 198 | 27 | int:CEBPA |
| Interaction | YWHAG interactions | TRAF3 GPBP1 CEP85L RPS2 RPS6KA1 STXBP4 SPTAN1 SRPK1 SYNE2 MIEF1 CAMSAP1 UTRN HSPA9 BICC1 LCA5 CAD RPGRIP1L DSP DNAH7 DCP1B VASH2 AKAP13 SLFN11 LZTS2 MTREX PATJ CEP170B | 9.48e-05 | 1248 | 198 | 27 | int:YWHAG |
| Interaction | EIF4G1 interactions | RPS2 EIF4A3 SRP14 HNRNPU BMI1 ZFYVE9 ZC3H7B GOLGA4 CAD UFL1 ZC3H7A SLC4A1AP SLFN11 MTREX | 1.02e-04 | 433 | 198 | 14 | int:EIF4G1 |
| Interaction | POLR1G interactions | PRPF31 KMT2B GATAD2A SCRN1 GPATCH4 CACTIN XPO5 BRPF1 UTP20 NIPBL SLC4A1AP PES1 STEEP1 LZTS2 CLSPN | 1.04e-04 | 489 | 198 | 15 | int:POLR1G |
| Interaction | RC3H2 interactions | RPS2 EIF4A3 SPTAN1 NACA SRP14 SRPK1 GPATCH4 HNRNPU CACTIN HSPA9 RPL36 CAD DSP U2SURP ZC3H7A CCT5 PES1 MTREX | 1.09e-04 | 667 | 198 | 18 | int:RC3H2 |
| Interaction | BIRC3 interactions | TRAF1 TRAF3 RPS2 EIF4A3 SPTAN1 NACA SRP14 F2 HNRNPU SAFB XPO5 UTP20 TLN2 HSPA9 GOLGA4 RANBP1 RPL36 CAD DSP SYNE1 U2SURP UFL1 FASTKD2 PRDM7 CCT5 PES1 MTREX SPEN | 1.16e-04 | 1334 | 198 | 28 | int:BIRC3 |
| Interaction | AGO3 interactions | 1.38e-04 | 153 | 198 | 8 | int:AGO3 | |
| Interaction | NUP50 interactions | NACA GPATCH4 ZNF318 HNRNPU XPO5 MCM3AP RANBP1 SLC4A1AP SMARCD3 SLFN11 CLSPN SPEN | 1.47e-04 | 341 | 198 | 12 | int:NUP50 |
| Interaction | ZC3H18 interactions | PRPF31 ZMYND11 RPS2 EIF4A3 NACA SRP14 SRPK1 GPATCH4 HNRNPU SAFB TLN2 HSPA9 RANBP1 RPL36 DSP U2SURP TEK PES1 MRPS33 MTREX SPEN | 1.54e-04 | 877 | 198 | 21 | int:ZC3H18 |
| Interaction | WWOX interactions | PRPF31 MYH7 TRAF3 HK2 EIF4A3 SRPK1 ERGIC2 TTC4 HNRNPU MYH16 CAD DSP U2SURP SLC4A1AP LRRCC1 LZTS2 SYMPK | 1.60e-04 | 627 | 198 | 17 | int:WWOX |
| Interaction | SRRM1 interactions | ZMYND11 EIF4A3 SRPK1 HNRNPU BMI1 SAFB SYNE2 RPL36 MYH7B UFL1 CCT5 AKAP13 | 1.78e-04 | 348 | 198 | 12 | int:SRRM1 |
| Interaction | TCEA2 interactions | 1.80e-04 | 159 | 198 | 8 | int:TCEA2 | |
| Interaction | DROSHA interactions | 2.17e-04 | 87 | 198 | 6 | int:DROSHA | |
| Interaction | CBX3 interactions | PCGF2 KMT2B ORC3 SRPK1 GPATCH4 HNRNPU ZNF518A BMI1 CACTIN NIPBL HSPA9 UFL1 SLC4A1AP STEEP1 SLFN11 CLSPN SPEN | 2.27e-04 | 646 | 198 | 17 | int:CBX3 |
| Interaction | LTBR interactions | 2.31e-04 | 88 | 198 | 6 | int:LTBR | |
| Interaction | IFI16 interactions | PRPF31 RPS2 SPTAN1 SRPK1 GPATCH4 HNRNPU BMI1 SAFB MCM3AP UTP20 HSPA9 RANBP1 SYNE1 U2SURP CCT5 SLC4A1AP PES1 MTREX | 2.51e-04 | 714 | 198 | 18 | int:IFI16 |
| Interaction | OTUD7A interactions | 2.61e-04 | 58 | 198 | 5 | int:OTUD7A | |
| Interaction | INSYN1 interactions | 2.73e-04 | 169 | 198 | 8 | int:INSYN1 | |
| GeneFamily | Myosin heavy chains | 5.32e-10 | 15 | 128 | 6 | 1098 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.68e-04 | 115 | 128 | 6 | 769 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.96e-04 | 4 | 128 | 2 | 1252 | |
| GeneFamily | PDZ domain containing | 7.47e-04 | 152 | 128 | 6 | 1220 | |
| GeneFamily | TNF receptor associated factors | 1.02e-03 | 7 | 128 | 2 | 1056 | |
| GeneFamily | Ring finger proteins|Polycomb group ring fingers | 1.02e-03 | 7 | 128 | 2 | 61 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.35e-03 | 8 | 128 | 2 | 939 | |
| GeneFamily | Cohesin complex | 1.35e-03 | 8 | 128 | 2 | 1060 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.16e-03 | 10 | 128 | 2 | 250 | |
| GeneFamily | Sterile alpha motif domain containing | 3.53e-03 | 88 | 128 | 4 | 760 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.69e-03 | 13 | 128 | 2 | 693 | |
| Coexpression | FISCHER_DREAM_TARGETS | GATAD2A STAG1 ORC3 GPATCH4 HMMR MCM10 HNRNPU ZNF518A EIF2AK3 NIPBL HSPA9 RAD51B RANBP1 CAD KNSTRN CCDC77 TBC1D31 PPP3CB CCT5 LRRCC1 CDK5RAP2 SLFN11 MTFR2 CLSPN | 6.12e-07 | 969 | 204 | 24 | M149 |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 1.84e-06 | 183 | 204 | 10 | M8178 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP | 9.05e-06 | 173 | 204 | 9 | M9425 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYND11 STAG1 HMMR MAP3K4 MGAT5 ZFYVE9 SYNE2 UTP20 KAZN SETD3 NIPBL GOLGA4 STRN3 DMXL2 U2SURP TBC1D31 PPP3CB AKAP13 MTREX SPEN | 1.31e-05 | 856 | 204 | 20 | M4500 |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 2.76e-05 | 199 | 204 | 9 | M7924 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP | 2.87e-05 | 200 | 204 | 9 | M8638 | |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP | 4.74e-05 | 165 | 204 | 8 | M6332 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TRAF3 SWT1 STXBP4 STAC3 SANBR HNRNPU ZNF518A NAA25 SAFB SYNE2 CAMSAP1 TAF13 STX17 EIF2AK3 NIPBL GOLGA4 RANBP1 DMXL2 RPGRIP1L DCP1B SLC4A1AP CLSPN | 6.67e-06 | 831 | 192 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 188 | 202 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 193 | 202 | 9 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-07 | 193 | 202 | 9 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-07 | 194 | 202 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-07 | 195 | 202 | 9 | 5001e68df2ad5df9dc93ae235f984ffafea6b521 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-07 | 195 | 202 | 9 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | GPATCH4 ZFYVE9 SYNE2 UTP20 SYNE1 APOBEC3H DCP1B GZMA CEP170B | 3.20e-07 | 198 | 202 | 9 | 717735d755745439f97ba1b71785c73945dfa9c5 |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.48e-07 | 200 | 202 | 9 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 152 | 202 | 8 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 172 | 202 | 8 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 183 | 202 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 186 | 202 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 187 | 202 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-06 | 187 | 202 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 188 | 202 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 188 | 202 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 188 | 202 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-06 | 188 | 202 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-06 | 189 | 202 | 8 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 2.59e-06 | 190 | 202 | 8 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 2.59e-06 | 190 | 202 | 8 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | Healthy/Control-CD4+_Tcm|World / Disease group and Cell class | 3.03e-06 | 194 | 202 | 8 | cbdd1786305108cbeddea07a21120067d78c59a0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.15e-06 | 195 | 202 | 8 | 07035a5972a78b98e4ab2167e3a5000f9f3b0826 | |
| ToppCell | BLOOD--(1)_Naive/CM_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.15e-06 | 195 | 202 | 8 | 97cf1a50a6d587a89a97666287e0a8ed271d014b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 197 | 202 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-06 | 197 | 202 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-06 | 197 | 202 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | (221)_CD8+_Naive_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.39e-06 | 197 | 202 | 8 | 59621a1f016b9f467e69bd5977ccdafa03b4ce21 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.39e-06 | 197 | 202 | 8 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | (2)_NK/T-(221)_CD8+_Naive_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.39e-06 | 197 | 202 | 8 | 5943f30288d4c9a7d7ef2e85461487a229f44511 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.52e-06 | 198 | 202 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.65e-06 | 199 | 202 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.65e-06 | 199 | 202 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-06 | 200 | 202 | 8 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.45e-06 | 153 | 202 | 7 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.45e-06 | 153 | 202 | 7 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.45e-06 | 153 | 202 | 7 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.45e-06 | 153 | 202 | 7 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.97e-06 | 158 | 202 | 7 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.38e-06 | 162 | 202 | 7 | b24298910eb39ea5103ae24439b3901205ed55b6 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TEM|Leuk-UTI / Disease, Lineage and Cell Type | 1.06e-05 | 165 | 202 | 7 | 08285c09de16ed4f488abb655a22f54bc07968ae | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.24e-05 | 169 | 202 | 7 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-05 | 177 | 202 | 7 | db6de487ef7976b444afadbf3ac60b3259925566 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 178 | 202 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-05 | 180 | 202 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 181 | 202 | 7 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega-Mega-Mast|blood / Manually curated celltypes from each tissue | 1.99e-05 | 182 | 202 | 7 | 1923b5669901f828e890416c22d1f1d21a4a2c6a | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 182 | 202 | 7 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 184 | 202 | 7 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 186 | 202 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-05 | 186 | 202 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.46e-05 | 188 | 202 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | mild_COVID-19-CD8+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.46e-05 | 188 | 202 | 7 | 60d27014e5f9e562efe2a602482ea1d07efd0331 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 188 | 202 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.46e-05 | 188 | 202 | 7 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_TCM|ICU-SEP / Disease, Lineage and Cell Type | 2.54e-05 | 189 | 202 | 7 | 9ed1cf4bb456780c1d1070de687bcabafd6287a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-05 | 189 | 202 | 7 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 189 | 202 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-05 | 190 | 202 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 190 | 202 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 191 | 202 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 191 | 202 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 2.72e-05 | 191 | 202 | 7 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.72e-05 | 191 | 202 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-05 | 191 | 202 | 7 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.81e-05 | 192 | 202 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Healthy_donor-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 2.81e-05 | 192 | 202 | 7 | 1603903454ba6bf65c8e13ede620e0b1e8fbd7ec | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 192 | 202 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-05 | 192 | 202 | 7 | bd91bf0ceeac49dc5a18aa2e401244db0ca596ae | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-05 | 192 | 202 | 7 | 18fbf485ad762ba7a9ac3e19bad136b0cf3af3c5 | |
| ToppCell | (1)_T_CD4_conv|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.81e-05 | 192 | 202 | 7 | 8dfa1d2730baab6f07b735d2f9984bb1712d3a65 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.90e-05 | 193 | 202 | 7 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-05 | 193 | 202 | 7 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.90e-05 | 193 | 202 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.90e-05 | 193 | 202 | 7 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-05 | 193 | 202 | 7 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 2.90e-05 | 193 | 202 | 7 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.90e-05 | 193 | 202 | 7 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 194 | 202 | 7 | 7c80fd2a70ee737d52738db6ad58577a15677fc4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.00e-05 | 194 | 202 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.00e-05 | 194 | 202 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 194 | 202 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 3.00e-05 | 194 | 202 | 7 | 390bf41cccfd586725a2fe653a299a78e261ec9b | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 194 | 202 | 7 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 194 | 202 | 7 | 1154625adeafa354d8cc847e26b75f4f37e4c39f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.00e-05 | 194 | 202 | 7 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 194 | 202 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 194 | 202 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 3.00e-05 | 194 | 202 | 7 | 6aeedfdb2b526913937eea978ddcbab8be4e49a6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.00e-05 | 194 | 202 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 194 | 202 | 7 | a1fabd408a74c2649a69e57e8865b79fdfe9047f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.00e-05 | 194 | 202 | 7 | 3844ef71804feef04948ff82fec4244e88fb63b2 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-05 | 195 | 202 | 7 | caa3669739974b63470f7e557df96e8d3844dd84 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 195 | 202 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Mild / Disease group, lineage and cell class | 3.10e-05 | 195 | 202 | 7 | 8aec807b24bcebf1a8011d676d2143b6fc570f1d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 195 | 202 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | HIP1 GATAD2A STAG1 RPS2 UTP20 ZC3H7B CAD NUCB2 RESF1 PES1 MTREX | 1.44e-06 | 195 | 202 | 11 | 1561_DN |
| Drug | plakin | 8.45e-06 | 82 | 202 | 7 | CID000018752 | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | HIP1 SRF HNRNPU MGAT5 UTP20 PLCB2 KAZN RAB3IL1 RPGRIP1L SYMPK | 1.01e-05 | 195 | 202 | 10 | 4466_DN |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | HNRNPU CACTIN MCM3AP CDC42EP2 UTRN RAD51B STRN3 THBS1 STEEP1 AKAP13 | 1.10e-05 | 197 | 202 | 10 | 5087_DN |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; HL60; HG-U133A | PRPF31 TPT1 TRAF3 STAG1 RPS2 SPTAN1 ZFYVE9 MCM3AP CAMSAP1 AKAP13 | 1.15e-05 | 198 | 202 | 10 | 1583_DN |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | CAPN9 CCDC134 PCGF2 SPTAN1 MCM3AP PREX2 VASH2 SMARCD3 AKAP13 PATJ | 1.15e-05 | 198 | 202 | 10 | 1689_UP |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; HL60; HT_HG-U133A | ZMYND11 ZFYVE9 MCM3AP ZC3H7B CAMSAP1 SLC25A17 SYNE1 RNF17 VASH2 PMFBP1 | 1.21e-05 | 199 | 202 | 10 | 2201_UP |
| Drug | NSC339663 | MYH7 MYH8 CLTCL1 MYH13 SRF EVPL SYNE2 MYH7B SYNE1 SHANK2 AVIL | 1.54e-05 | 250 | 202 | 11 | CID000003892 |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HG-U133A | 6.17e-05 | 194 | 202 | 9 | 1925_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 6.17e-05 | 194 | 202 | 9 | 4455_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.42e-05 | 195 | 202 | 9 | 7239_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | HIP1 PCGF2 SPTAN1 ZFYVE9 CDC42EP2 KAZN RAB3IL1 SLC25A17 SMARCD3 | 6.42e-05 | 195 | 202 | 9 | 3472_UP |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.42e-05 | 195 | 202 | 9 | 7152_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 6.42e-05 | 195 | 202 | 9 | 1366_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | PCGF2 CACTIN GUF1 PLCB2 ZC3H7B CAMSAP1 RAB3IL1 PPP3CC SMARCD3 | 6.42e-05 | 195 | 202 | 9 | 2432_DN |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | PCGF2 CACTIN ZC3H7B TAF13 RAB3IL1 SYNE1 THBS1 CEP170B PMFBP1 | 6.67e-05 | 196 | 202 | 9 | 3069_DN |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; HL60; HG-U133A | 6.67e-05 | 196 | 202 | 9 | 1591_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 202 | 9 | 1178_DN | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; HL60; HG-U133A | 6.94e-05 | 197 | 202 | 9 | 1587_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RPS2 SPTAN1 CACTIN ZC3H7B RAB3IL1 SLC25A17 THBS1 SHANK2 SYMPK | 6.94e-05 | 197 | 202 | 9 | 4745_DN |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 2638_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.22e-05 | 198 | 202 | 9 | 7028_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | ABCB7 MCM3AP CDC42EP2 ZC3H7B HSPA9 PPP3CC VASH2 CDK5RAP2 SPEN | 7.22e-05 | 198 | 202 | 9 | 6983_DN |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | KMT2B SPTAN1 EVPL CDC42EP2 ZC3H7B CAMSAP1 SUPT3H SYNE1 SMARCD3 | 7.22e-05 | 198 | 202 | 9 | 5059_DN |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | 7.22e-05 | 198 | 202 | 9 | 1553_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.50e-05 | 199 | 202 | 9 | 7020_DN | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 7.50e-05 | 199 | 202 | 9 | 7422_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.50e-05 | 199 | 202 | 9 | 4278_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 7.79e-05 | 200 | 202 | 9 | 3425_UP | |
| Drug | sulfur dichloride | 7.83e-05 | 2 | 202 | 2 | CID000025353 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.01e-09 | 10 | 196 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 9.37e-09 | 12 | 196 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 9.37e-09 | 12 | 196 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.51e-08 | 13 | 196 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.44e-08 | 71 | 196 | 8 | DOID:0050700 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.50e-08 | 15 | 196 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.74e-07 | 48 | 196 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.08e-06 | 80 | 196 | 7 | DOID:12930 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.91e-06 | 7 | 196 | 3 | C0751337 | |
| Disease | Malignant neoplasm of breast | CEP85L STXBP4 SPTAN1 ZNF318 HMMR NAA25 SYNE2 UTP20 CNGA2 NIPBL RAD51B RANBP1 SFRP5 SYNE1 TEK THBS1 CCT5 LZTS2 CLSPN SPEN | 3.45e-05 | 1074 | 196 | 20 | C0006142 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.61e-04 | 4 | 196 | 2 | cv:CN293514 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 2.61e-04 | 4 | 196 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.61e-04 | 4 | 196 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 4.05e-04 | 22 | 196 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.33e-04 | 5 | 196 | 2 | C1450051 | |
| Disease | pulmonary embolism (is_implicated_in) | 4.33e-04 | 5 | 196 | 2 | DOID:9477 (is_implicated_in) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.33e-04 | 5 | 196 | 2 | C0410190 | |
| Disease | cerebellar ataxia (is_implicated_in) | 4.33e-04 | 5 | 196 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.47e-04 | 6 | 196 | 2 | cv:C0410189 | |
| Disease | Pathologic Neovascularization | 6.47e-04 | 6 | 196 | 2 | C0027686 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.47e-04 | 6 | 196 | 2 | C0410189 | |
| Disease | mean reticulocyte volume | ABCB7 GATAD2A EIF4A3 RPS6KA1 STXBP4 SRPK1 ZNF318 SAFB TLN2 RAD51B CAD RESF1 AKAP13 PMFBP1 | 9.64e-04 | 799 | 196 | 14 | EFO_0010701 |
| Disease | LDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 1.20e-03 | 8 | 196 | 2 | EFO_0007804, GO_1901557, GO_1903491 | |
| Disease | Sideroblastic anemia | 1.53e-03 | 9 | 196 | 2 | C0002896 | |
| Disease | renal Wilms' tumor (is_implicated_in) | 1.91e-03 | 10 | 196 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | serum alanine aminotransferase measurement | CCDC134 STAG1 SRP14 NAA25 ABCC2 RAD51B MYH7B ZC3H7A THBS1 MLIP RESF1 FEZ1 PATJ PMFBP1 | 2.11e-03 | 869 | 196 | 14 | EFO_0004735 |
| Disease | level of Ceramide (d40:1) in blood serum | 2.32e-03 | 11 | 196 | 2 | OBA_2045185 | |
| Disease | colorectal cancer | CAPN9 HIP1 STIMATE NAA25 KAZN CAMSAP1 SETD3 BICC1 CFAP44 SMC1B SYMPK | 2.49e-03 | 604 | 196 | 11 | MONDO_0005575 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.77e-03 | 12 | 196 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | hair colour measurement | TRAF1 GAS8 SAMD12 SYNE2 MED12L STX17 RAD51B SUPT3H MYH7B PRDM7 AKAP13 | 2.85e-03 | 615 | 196 | 11 | EFO_0007822 |
| Disease | triacylglycerol 56:6 measurement | 2.93e-03 | 43 | 196 | 3 | EFO_0010433 | |
| Disease | schizophrenia (is_marker_for) | 3.13e-03 | 44 | 196 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Intellectual Disability | ZMYND11 PCGF2 STAG1 EIF4A3 HNRNPU MED12L SYNE1 SHANK2 CTNNA2 | 3.15e-03 | 447 | 196 | 9 | C3714756 |
| Disease | Fetal Alcohol Spectrum Disorders | 3.26e-03 | 13 | 196 | 2 | C2985290 | |
| Disease | coronary artery calcification | 3.29e-03 | 450 | 196 | 9 | EFO_0004723 | |
| Disease | Primary Ciliary Dyskinesia | 3.78e-03 | 47 | 196 | 3 | C4551720 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.79e-03 | 14 | 196 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | gamma-glutamylglutamate measurement | 3.79e-03 | 14 | 196 | 2 | EFO_0021137 | |
| Disease | obsolete_interleukin-12 subunit B measurement | 3.79e-03 | 14 | 196 | 2 | EFO_0010787 | |
| Disease | diacylglycerol 38:4 measurement | 3.79e-03 | 14 | 196 | 2 | EFO_0020066 | |
| Disease | Left ventricular noncompaction | 3.79e-03 | 14 | 196 | 2 | C1960469 | |
| Disease | rheumatoid arthritis | TRAF1 KMT2B STAG1 RAD51B ZC3H7A PHACTR3 CDK5RAP2 CEP170B SMC1B | 3.91e-03 | 462 | 196 | 9 | EFO_0000685 |
| Disease | QRS duration | 3.91e-03 | 298 | 196 | 7 | EFO_0005055 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 4.04e-03 | 225 | 196 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | overall survival, pancreatic carcinoma | 4.25e-03 | 49 | 196 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | Replication Error Phenotype | 4.35e-03 | 15 | 196 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 4.35e-03 | 15 | 196 | 2 | C0920269 | |
| Disease | body weight | TRAF3 SPOCK1 STXBP4 ADCY6 TTC19 NAA25 TLN2 KAZN EIF2AK3 NIPBL PDZRN4 RPGRIP1L MOXD1 MLIP TBC1D31 CTNNA2 PATJ | 4.61e-03 | 1261 | 196 | 17 | EFO_0004338 |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 4.67e-03 | 101 | 196 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.95e-03 | 16 | 196 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | HIV Infections | 5.00e-03 | 103 | 196 | 4 | C0019693 | |
| Disease | leprosy | 5.00e-03 | 103 | 196 | 4 | EFO_0001054 | |
| Disease | HIV Coinfection | 5.00e-03 | 103 | 196 | 4 | C4505456 | |
| Disease | Fetal Alcohol Syndrome | 5.59e-03 | 17 | 196 | 2 | C0015923 | |
| Disease | Ciliopathies | 6.30e-03 | 110 | 196 | 4 | C4277690 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 6.30e-03 | 110 | 196 | 4 | EFO_0803335 | |
| Disease | idiopathic pulmonary fibrosis | 6.49e-03 | 57 | 196 | 3 | EFO_0000768 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EQIMGKDVRLLRIKK | 446 | Q9Y6N9 | |
| KTVKLMKEGLEAARL | 226 | Q93088 | |
| DALLEKKKLMAARER | 296 | P28222 | |
| SGERLKAMLLAKDIR | 181 | O75366 | |
| LAREKVMREVKALAK | 631 | Q9NZJ5 | |
| LILGASQKRKEEKAM | 551 | O43306 | |
| MRRLNRKKTLSLVKE | 1 | Q96RQ1 | |
| REGDLKLLQLMEKAK | 111 | P12544 | |
| KMLEELDKNSRAIKR | 161 | Q6NTF7 | |
| KKMLDTRARELKEQL | 2351 | Q12802 | |
| EIFKDRTNKMGKRLQ | 386 | Q9BR77 | |
| GNLLKSLIGKKEMRI | 6 | P61204 | |
| QLLELMDLGKVRRAK | 1351 | Q8TDJ6 | |
| AKKLSRLDILAMPRK | 1161 | Q9Y4F5 | |
| QRMEKEKRTLLERKL | 196 | Q9H2F9 | |
| GARRKMLLAISELNK | 921 | Q9H694 | |
| KRKLQAMRDIAILKE | 101 | Q6ZUS5 | |
| KKKMEALSARQRLKL | 896 | Q5T5Y3 | |
| KHELGLMKLKNRFRD | 1011 | Q96MT7 | |
| RDKAIQGLTMALKSK | 316 | Q96SN8 | |
| MELEKREKRSLLNKN | 1 | Q5VWP3 | |
| SEKQLKEARGKIDML | 136 | Q8TBN0 | |
| MGSKKLKRVGLSQEL | 1 | O15315 | |
| KEKGAIRLLMRRDKT | 81 | P43487 | |
| LKERALKIKEERSGM | 911 | Q6ZMN7 | |
| FILEGKENREKRMIK | 296 | Q6ZSC3 | |
| GGDITRKMKLLKRQA | 626 | Q8N442 | |
| MDLERAKRKLEGDLK | 1046 | P12883 | |
| LRNKEVKAAMRKLVT | 291 | A0A0X1KG70 | |
| KQKERELRLLMLGLD | 11 | P36404 | |
| SKKIKMERGLLASDL | 26 | Q86YP4 | |
| IALLAARKNKILEMK | 156 | P19113 | |
| RMKKKRLLLREQALS | 266 | P31275 | |
| RNKDMKDALKRVLGL | 311 | Q8NGC7 | |
| EALQAMKADRKRLKG | 136 | Q674X7 | |
| MKADRKRLKGEKTDL | 141 | Q674X7 | |
| GKHRAMAVAKLLEKR | 521 | Q86YW9 | |
| SGKLEKNMEKILIRP | 131 | Q9BRK4 | |
| QEDKIKRMATKLIRL | 71 | Q68CZ1 | |
| KRMATKLIRLVNDKK | 76 | Q68CZ1 | |
| LAELKEIMKKVVGNR | 321 | Q09328 | |
| RMKQKKREREGLLAT | 281 | Q9GZZ0 | |
| RMLVIKKGNTKDLQL | 171 | Q86WP2 | |
| KLGKEIVRLQKDLRM | 1941 | Q13439 | |
| RLKEMKLLRDQFVKA | 151 | Q8IZU0 | |
| SLMKGLKRKEDQDRS | 286 | O60318 | |
| GSARKRLLKEEDMTK | 11 | P38919 | |
| KRELKQKMRNLFERG | 1981 | Q8IVV2 | |
| KLVPGLFKNEMKRRR | 81 | P35226 | |
| LLEISKRFRKEMEKG | 36 | P52789 | |
| LKGMLKEIKPRLSRN | 76 | Q86SG4 | |
| ARLGITMKAKLARLE | 161 | Q5T3I0 | |
| RVRQKLEKEKSELRM | 1261 | A7E2Y1 | |
| ARNEALRLKKKMEGD | 1656 | A7E2Y1 | |
| LRLKKKMEGDLNDLE | 1661 | A7E2Y1 | |
| KLRMDLERAKRKLEG | 1046 | P13535 | |
| RNDALRVKKKMEGDL | 1611 | P13535 | |
| RQLLKKRMKLSSLDV | 191 | O43808 | |
| KMALRGKALRTQLDL | 376 | P55058 | |
| LRNKEVKAAMRKLVT | 291 | Q8NGB6 | |
| TRLKAKLQEMAGKRS | 1211 | Q92817 | |
| KKRRLSDKGLKAELM | 21 | Q00839 | |
| KMIRRVNDEEGIKKL | 1891 | Q6KC79 | |
| TRVLQEKLRKLKEAM | 371 | Q8WY64 | |
| LLLVRMGRKAAGLKK | 176 | Q6UWV2 | |
| GVDLITRKEKKANLM | 591 | Q86VQ0 | |
| DKRLKIMNEILSGIK | 496 | Q92887 | |
| ELMKKRRKEKGLSLQ | 286 | Q99689 | |
| DKIEARKMERLAKKG | 1006 | Q9UMN6 | |
| NKKMTGRKLIRLSQI | 266 | Q7L590 | |
| GRKLIRLSQIKEKMA | 271 | Q7L590 | |
| RLSQIKEKMAREKLE | 276 | Q7L590 | |
| KGQVDLKKSRLRMSL | 121 | Q9NQG6 | |
| SIRNKDMKAALGKLI | 291 | O60431 | |
| VGRLRMLIKAKLDSL | 111 | P80303 | |
| LKEEISKMRELLARK | 611 | P38646 | |
| MTKKKRENLGVALEI | 1 | Q9P0B6 | |
| KLVPGLFKDEMKRRR | 81 | P35227 | |
| LSLELMKLRNKRETK | 166 | O75330 | |
| GKEVDILRMLIKAKD | 156 | Q8IZD4 | |
| MKANETKLEGDKRRL | 1626 | Q5TZA2 | |
| MEKLKRLLQVAARKS | 436 | Q96CN9 | |
| LEKMKEIREQRIKSG | 716 | Q13099 | |
| GKKEKLRDLLSSDMI | 16 | O14613 | |
| KKKRGMENILRKSDL | 206 | Q96BT1 | |
| IDKMTKKTRDLRRQL | 366 | P26232 | |
| IKKNLIDRETGMRLL | 2111 | P15924 | |
| QNIVMSKLDKRRKGV | 2016 | Q8WXX0 | |
| IAMDGLRKKQAALKE | 2826 | Q8WXX0 | |
| ESMLKIKEGLLRQKE | 361 | Q5SZL2 | |
| KVKQLRLEREREKAM | 246 | Q8WUQ7 | |
| KKNKIKLSARRDLIM | 161 | Q58FG1 | |
| FLVALMQKDRRKLKR | 396 | O14815 | |
| RKEIIRNKIRAIGKM | 401 | P16298 | |
| RAMELLKVSKDKRAL | 56 | Q9Y3U8 | |
| LRNKDMKGSLGRLLL | 291 | O60412 | |
| KSLLEMKELRRSKKQ | 531 | Q9UBD5 | |
| EEVRAKSKLLEKMQR | 806 | Q9P2E2 | |
| KSKLLEKMQRKLRAA | 811 | Q9P2E2 | |
| TLRNKDMKEALRKLL | 291 | Q8NGZ4 | |
| MRNAIEKLLGKKLTI | 291 | Q8NH83 | |
| EMDKESILRKIGQAK | 486 | Q4G0U5 | |
| DKALKQMGLRKLILR | 531 | Q9Y6R4 | |
| EKKMAGRQGREELIK | 96 | Q96KR7 | |
| RMKKLNTELRKLRGF | 786 | Q8TBY8 | |
| QDFMDEQKRLKKLRG | 76 | Q9Y291 | |
| RARALKKLAKQLMEG | 1586 | O75691 | |
| KQDLERASQLARKMK | 1536 | P46939 | |
| GQENLKKDLVRRIKM | 106 | Q13033 | |
| EKQLERKGMSKRRLQ | 186 | Q9H5V9 | |
| NRRLALELMKKAASK | 746 | Q68CR1 | |
| QRLAAVKRELKVKEM | 756 | Q96DN5 | |
| MLTLASKLKRDDGLK | 1 | Q969M7 | |
| KRGLLTRLLQVMKKE | 511 | Q8TEL6 | |
| MRIKEIKIENGDRKL | 206 | Q5T4F7 | |
| ELRDKTTMLGKAKLL | 3421 | Q8NF91 | |
| AKQMLLKSLIKDADR | 4396 | Q8NF91 | |
| GKLTFENIMEKLRIK | 3631 | Q8WXH0 | |
| KRERKAAKTLGIAMA | 251 | Q96RI9 | |
| KNMGIDVRLKVLLDK | 361 | Q7L592 | |
| AKLIQRAEEMKSGLK | 1181 | P0DJD1 | |
| ARKIKINKDLLMAAG | 411 | Q9HCM1 | |
| SKNTRKAREMLLKLA | 136 | Q8N565 | |
| GKLMRIKFQKILEER | 806 | Q9Y2K3 | |
| SLRNKDVKEALRKVM | 291 | Q8NGL2 | |
| SLRNKDMKGTLRKFI | 291 | Q8NG99 | |
| SLRNKDMLKALRKLI | 291 | Q8NG95 | |
| APIALKRKLEMKALR | 321 | Q9NYY8 | |
| KRKLEMKALRELDRF | 326 | Q9NYY8 | |
| AKDQRKMLLVGSRKA | 616 | O00291 | |
| RLKLELRRKETEGKM | 166 | Q9NQW5 | |
| TKITKLRRENGQMKA | 136 | Q9Y448 | |
| RSAKRRKMADKILPQ | 96 | Q6STE5 | |
| KELKEFQKILGMHRR | 191 | Q92565 | |
| DLSVRAKMAIKLRLG | 456 | Q86TU7 | |
| AKMAIKLRLGEKEIL | 461 | Q86TU7 | |
| LLKAMRKKRVVQLSD | 826 | Q7Z7L1 | |
| FLIIKDQDRKSRLMG | 16 | P48643 | |
| DQDRKSRLMGLEALK | 21 | P48643 | |
| LLRLTDKKLERMGIA | 111 | Q8N8I0 | |
| KDLLTMNEELKRARK | 101 | Q15543 | |
| MERKVLALQARKKRT | 1 | Q96SB4 | |
| LLVQREKMKELKKGR | 176 | Q5T5J6 | |
| MRLGDLDRVKSKEAK | 661 | Q6NSI8 | |
| DLKKRIMVLDCQLRK | 401 | Q6ZWJ1 | |
| RKLRSTMLELEKQGL | 366 | Q12765 | |
| SGNKSVLMERLKKAI | 51 | Q15424 | |
| RGRVKIKMEFIDNKL | 141 | P11831 | |
| ERLKPAGRKMSLRNK | 311 | Q16533 | |
| LGRDRKGDDKKNMLI | 1286 | Q9UPX8 | |
| RAKLREIELKVMKFQ | 841 | O15042 | |
| GLKDVDTRKIIKAML | 111 | O75027 | |
| LDKEKMLEGRKSNIR | 1171 | P55201 | |
| KKMFEVKRREQLLAL | 36 | Q9H6E4 | |
| EDLVKFLQMARKKGR | 1151 | P53675 | |
| AKKVLEERGREILMK | 566 | Q16280 | |
| ELLKRSEKLKRQMRL | 1036 | Q9HAW4 | |
| EKGREILLKMNKLDV | 466 | Q8IV77 | |
| LRKLEENLKTMGRLS | 1011 | Q9BXT8 | |
| RKEIIRNKIRAIGKM | 386 | P48454 | |
| KMNLVDRLKRLGIAR | 831 | O60296 | |
| IIQLLKRAKLSIMKD | 96 | Q6DKK2 | |
| KRRKQEAVMGKTLSL | 426 | Q13114 | |
| QMKKTRGTLLALERK | 96 | P07996 | |
| LQAEKKLLSKMAGRS | 11 | Q6P589 | |
| EDLLFLMRKDKKKLR | 81 | O75486 | |
| GIRLRHFRKGKEMKL | 396 | Q6UVY6 | |
| KADKEGIAKNRLELM | 861 | Q96T58 | |
| KRELKKARTVLQMDE | 836 | P42285 | |
| IMFGKRRKIREANKL | 551 | O00541 | |
| LLRANMDGLKKRDKK | 86 | P37108 | |
| MIKKRKGLRLIDALV | 161 | Q9H5L6 | |
| DRRSQKIQELKGLMK | 676 | Q8NDV3 | |
| LDRLKMKLQEKGDTS | 16 | Q8NI35 | |
| EKMKELSLKRRGSKD | 491 | Q5TF21 | |
| CLKVRKDDLVLLKRM | 76 | P56962 | |
| LKAQMIEKRSKLGES | 1536 | Q13813 | |
| MKSIKGKLEEQRPER | 96 | P13693 | |
| KMKERLGLTEIRKQA | 361 | Q8WWY3 | |
| EMNRIQKLSKGKSLL | 316 | Q08629 | |
| SRKGKLEDRKPLMVL | 276 | Q9HAV4 | |
| DLKLKVMDLRGKFKR | 96 | P19237 | |
| DLERAKRKLEGDLKM | 1051 | Q9UKX3 | |
| SRNDALRLKKKMEGD | 1611 | Q9UKX3 | |
| FMKEKLLAELEGKLR | 181 | Q13077 | |
| NKMIGKRANERLELL | 256 | Q8WVM7 | |
| VSKMLRADIRKELEK | 271 | Q86V25 | |
| ILKERERRKGLKLGM | 356 | Q70Z35 | |
| ELLRIAKKLEKMVAR | 6 | O75764 | |
| FLMRKGKTKAKLEER | 216 | Q86TL2 | |
| GQVLKARIKKDGLRM | 836 | Q02763 | |
| ARIKKDGLRMDAAIK | 841 | Q02763 | |
| EKRMAKTSAGLKLIL | 301 | Q6AHZ1 | |
| KLETKRLERIQGMTK | 1046 | Q00722 | |
| VQKERSLDILKGKVM | 1951 | P27708 | |
| MKLGAVKRILRAEKA | 561 | Q92797 | |
| VLKDMNKVKLRAIER | 276 | Q6P444 | |
| RAEALRLKKKMETDL | 771 | Q9H6N6 | |
| RRDALKMKLNKARKD | 936 | Q8IWR0 | |
| RENKGKLRKEMLLSV | 356 | P42681 | |
| VSRMKERAIDLNKKG | 166 | Q15326 | |
| TLKKDRTLLRDERKM | 146 | Q9Y4G6 | |
| RTLLRDERKMEKLKA | 151 | Q9Y4G6 | |
| RENLDRDIALMKLKK | 456 | P00734 | |
| KLAKRNAAAKMLLRV | 211 | Q15633 | |
| LGRLVKDMKIKSLEE | 66 | P15880 | |
| VKRLGKLLSESMKQA | 731 | Q9P2L0 | |
| LRTGVIMANKERKKG | 181 | Q96MF2 | |
| KLLEMRAKADKLKRI | 186 | O95801 | |
| ERLGRKREQLIEKKM | 1796 | Q6ZQQ6 | |
| KAMVQGKKRLRGELD | 1941 | Q6ZQQ6 | |
| LERLHKQQGEMLRKK | 916 | Q5VUA4 | |
| GIGKAKLRSMKERKL | 356 | Q9NQA3 | |
| LKLLKEDGMTKLGLR | 1351 | O95405 | |
| IMVKRGDKKRERQIL | 651 | O94874 | |
| MERQKRKADIEKGLQ | 1 | Q9UGR2 | |
| SVLRKDMRALKVELK | 136 | O95995 | |
| DRKETMTLILKAKLG | 266 | Q15418 | |
| LMRGGELLDKILRQK | 491 | Q15418 | |
| LRTLEKTLEKMERQK | 521 | Q9C099 | |
| RSEKKARKAMSKLGL | 71 | Q13765 | |
| GLIEKKRLNRMKKAG | 476 | Q9BWU0 | |
| MGELLKKRLETTKKL | 956 | Q14CX7 | |
| TDLRGMLKRLKKAKV | 236 | Q14324 |